Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Pomalidomide, dexamethason en daratumumab bij RRMM na falen lenalidomide
jul 2020 | MM